Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Adenomatous Polyposis Coli

• FOG-001 in Locally Advanced or Metastatic Solid Tumors
• Testing ONC201 to Prevent Colorectal Cancer
• Efficacy and Safety of REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
• The CHAMP-study: The CHemopreventive Effect of Lithium in Familial AdenoMatous Polyposis
• Testing Obeticholic Acid for Familial Adenomatous Polyposis
• Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)
• A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis
• Azithromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
• Niclosamide for Familial Adenomatous Polyposis
• Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
• Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis
• A Study of Guselkumab in Participants With Familial Adenomatous Polyposis
• Primary Chemoprevention of Familial Adenomatous Polyposis With Berberine Hydrochloride
• Sirolimus and Familial Adenomatous Polyposis (FAP)
• Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
• 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
• Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutation in Familial Adenomatous Polyposis-minors' Adjusted Version
• Erythromycin Treatment for Readthrough of APC Gene Stop Codon Mutations in Familial Adenomatous Polyposis
• Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW
• The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study
• Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
• A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
• A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
• Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
• Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
• Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)
• Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
• Curcumin in Treating Patients With Familial Adenomatous Polyposis
• Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
• Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA
• Molecular Targeting of 15-Lipoxygenase-1 (15-LOX-1) for Apoptosis Induction in Human Colorectal Cancers
• Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
• Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
• Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
• A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)
• Ursodeoxycholic Acid in the Treatment of Duodenal Adenomas in Familial Adenomatous Polyposis (FAP) Patients
• Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis